Procter & Gamble Co.

PG ·Consumer Defensive, Household & Personal Products, United States

The Procter & Gamble Company (PG)

Overview

Procter & Gamble is one of the world's largest manufacturers of branded consumer packaged goods, headquartered in Cincinnati, Ohio, and tracing its roots back to 1837. It operates in the consumer staples sector, competing primarily in personal care, home care, and health categories sold through retail channels worldwide. For fiscal year 2025 (ended June 30, 2025), P&G reported net sales of $84.3 billion and net earnings of $16.1 billion, with organic sales growth of 2% marking its 39th consecutive quarter of top-line growth. The company employs roughly 109,000 people globally and sells products in more than 180 countries through a portfolio of around 65 brands, ten of which — including Tide, Pampers, and Gillette — each generate over $1 billion in annual sales.

What They Do & How They Make Money

P&G's business model is straightforward in concept but executed at enormous scale: it develops, manufactures, and markets branded household and personal-care products, then sells them primarily through mass retailers, grocery chains, drugstores, club stores, and, increasingly, e-commerce. Revenue is generated almost entirely from product sales rather than services or licensing — P&G designs a product (a laundry detergent, a razor, a diaper), builds a recognizable brand around it through heavy advertising and R&D-driven differentiation, and then relies on scale manufacturing and a dense global distribution network to get it onto shelves and into online carts at a price point that supports a premium over generic alternatives. The company's largest customer relationships are with big-box and club retailers such as Walmart, which alone accounts for a meaningful share of total sales, making retail-partner relationships as important to the model as consumer brand loyalty itself. E-commerce has become a growing share of the mix — up 12% in fiscal 2025 and now roughly 19% of total sales — supplementing but not replacing the traditional brick-and-mortar retail backbone. Profitability comes from a combination of premium pricing enabled by brand equity, continuous productivity and cost-cutting programs, and the operating leverage that comes from selling the same handful of "superiority" innovations (better-performing formulas, packaging, and experience) across a global manufacturing and logistics footprint.

Business Segments

P&G reports results across five segments. Figures below are net sales and net earnings for fiscal year 2025 (ended June 30, 2025):

Fabric & Home Care — $29.6 billion in net sales, $5.8 billion in net earnings; the largest segment, roughly 35% of total sales. Key brands: Tide, Ariel, Downy, Gain, Cascade, Dawn, Febreze, Mr. Clean, Swiffer, Ambi Pur, Lenor.
Baby, Feminine & Family Care — $20.2 billion in net sales, $4.0 billion in net earnings (about 24% of sales). Key brands: Pampers, Luvs, Always, Whisper, Tampax, Bounty, Charmin, Puffs.
Beauty — $15.0 billion in net sales, $2.7 billion in net earnings (about 18% of sales), the only segment to see sales decline in fiscal 2025 (down roughly 2%). Key brands: Olay, Head & Shoulders, Pantene, SK-II, Old Spice, Secret.
Health Care — $12.0 billion in net sales, $2.4 billion in net earnings (about 14% of sales), the fastest-growing segment in fiscal 2025 with 2% organic growth. Key brands: Crest, Oral-B, Vicks, Metamucil, Pepto-Bismol.
Grooming — $6.7 billion in net sales, $1.6 billion in net earnings (about 8% of sales). Dominated by Gillette, alongside Braun and Venus.

Fabric & Home Care and Baby/Feminine & Family Care together make up roughly 60% of company-wide net sales and generate the bulk of P&G's operating profit, reflecting the scale and everyday-necessity nature of those categories.

Competitors

P&G's competitive set varies by segment but overlaps heavily with a handful of large multinational consumer goods companies, plus a growing private-label threat across nearly every category:

Fabric & Home Care: Unilever, Church & Dwight, Henkel, Reckitt Benckiser, Clorox, Colgate-Palmolive, and retailer private-label detergents/cleaners.
Baby, Feminine & Family Care: Kimberly-Clark (Huggies, Kotex), Essity, Unicharm, and store-brand diapers/paper products.
Beauty: Unilever, L'Oréal, Estée Lauder, Coty, Shiseido, and Kenvue's beauty-adjacent brands.
Health Care: Colgate-Palmolive (oral care), GSK Consumer Health/Haleon, Kenvue (Johnson & Johnson's former consumer health spin-off), Reckitt Benckiser.
Grooming: Edgewell Personal Care (Schick), BIC, Harry's, and a wave of direct-to-consumer razor subscription brands.

Beyond branded rivals, P&G faces broad, cross-category competition from private-label and store-brand products at Walmart, Costco, Target, Aldi, and European discounters, which have gained share as inflation-weary consumers trade down.

Competitive Position

P&G's core competitive advantage is the combination of an unusually deep portfolio of category-leading, decades-old brands with the scale to out-advertise, out-innovate, and out-distribute smaller rivals. Roughly a dozen of its brands are billion-dollar franchises, and many — Tide, Pampers, Gillette, Crest — hold number-one or number-two positions in their categories globally, giving P&G leverage in negotiations with retailers and pricing power with consumers who default to trusted names for everyday purchases. Its manufacturing and supply-chain scale, combined with sustained R&D investment (aimed at continuous "superiority" upgrades to product performance, packaging, and communication), lets it defend share even as private-label alternatives close the quality gap. The balance sheet and cash generation are also a structural strength: P&G produced roughly $17.8 billion of operating cash flow in fiscal 2025 and has raised its dividend for 69 consecutive years, underscoring the durability of its cash flows even in a slow-growth environment.

That said, the company faces real headwinds. Growth has been sluggish and uneven — Beauty sales declined in fiscal 2025, and management has guided to a flat-to-3% organic sales outlook for fiscal 2026, below prior expectations, contributing to the stock trailing peers such as Colgate-Palmolive, Church & Dwight, and Clorox over the past year. Tariffs are a fresh and material cost pressure, with the company estimating roughly $900 million of tariff-related headwinds (about $300 million tied to China and $600 million from other regions), prompting mid-single-digit price increases on about a quarter of its SKUs — a move that risks accelerating trade-down to private label if consumers balk. In response, P&G announced in mid-2025 a two-year restructuring plan to cut up to 7,000 non-manufacturing jobs (about 15% of that workforce) and streamline its brand portfolio, while new CEO Shailesh Jejurikar, who took over on January 1, 2026, faces pressure to reaccelerate growth. Longer-running risks include volatile commodity and input costs (resins, pulp, packaging), foreign-exchange exposure given P&G's heavily international sales base, geopolitical and consumer-spending volatility in developing markets, and the steady erosion of pricing power in mature categories as private-label quality improves and e-commerce makes price comparison easier for shoppers.